Report cover image

Emerging Market Outsourcing Report - Q3 2025

Publisher GlobalData
Published Sep 30, 2025
Length 22 Pages
SKU # GBDT20495283

Description

Emerging Market Outsourcing Report - Q3 2025

Summary

This expert outsourcing report is a comprehensive look at the pharmaceutical manufacturing landscape for emerging markets in Q3 2025, including analysis of news and trends affecting contract manufacturing organizations (CMOs) and the identification of recent contract service agreements, mergers, acquisitions, and financing among CMOs. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the pharmaceutical value chain that will provide insights into API (biologics and chemical) as well as dose manufacturing and packaging (clinical and commercial) for countries in emerging markets.

Scope

This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from GlobalData's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for -
  • CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
  • Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
  • Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy

This report will enable the user to answer the following questions -
  • What are the latest trends in contract service agreements within the emerging markets of the pharmaceutical industry such as India, China, the Middle East, South America, and Eastern Europe?
  • What mergers and acquisitions have occurred in the pharmaceutical sector during Q2 2025, and what do they signify for the industry?
  • How are global supply chains for active pharmaceutical ingredients (APIs) being affected by regulatory changes and inspections?
  • What are the key challenges and opportunities for contract research, development, and manufacturing organizations (CRDMOs)?
  • What are the outcomes of FDA inspections and compliance issues for pharmaceutical manufacturers?

Table of Contents

22 Pages
1 Industry Trends
1.1 Pharmaceutical firms in India criticize new manufacturing regulations imposed by the CDSCO
1.2 China’s 11th Centralized Procurement Program marks milestone with improved bidding, price setting to ease excessive low-price competition
2 Industry Analysis
2.1 Emerging market contract service agreements
2.2 Emerging market quarterly mergers, acquisitions, and financing – Q3 2025
3 Value Chain
3.1 API chemical
3.1.1 China
3.1.2 India
3.2 API biologics – protein and peptide
3.2.1 China
3.2.2 India
3.2.3 Singapore
3.3 API biologics (cell, gene, vaccine, and virus therapies)
3.3.1 Egypt
3.4 Clinical dose manufacturing and packaging
3.4.1 India
3.5 Commercial dose manufacturing and packaging
3.5.1 China
3.5.2 India
3.5.3 Taiwan
3.6 Analytical services
3.6.1 India
3.7 Regulatory developments
3.7.1 India
3.7.2 Moldova
3.7.3 Vietnam
2 About the Authors
3 About GlobalData
4 Contact Us
List of Tables
Table 1: Contract service agreements
Table 2: Mergers, acquisitions, and financing – Q3 2025
List of Figures
Figure 1: Deals by deal geography, by volume
Figure 2: Deals by deal geography, by volume
Figure 3: The contract manufacturing value chain

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us